HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Alzheimer’s Disease Neuroimaging Initiative Selected Research
Alzheimer’s Disease Neuroimaging Initiative Research Topics
Disease
604
Alzheimer Disease (Alzheimer's Disease)
05/2024 - 09/2010
335
Cognitive Dysfunction
04/2024 - 09/2010
159
Dementia (Dementias)
05/2024 - 01/2012
118
Atrophy
04/2024 - 01/2012
60
Disease Progression
04/2024 - 01/2012
30
Neurodegenerative Diseases (Neurodegenerative Disease)
03/2024 - 10/2016
15
Genetic Risk Score
05/2024 - 01/2017
14
Inflammation (Inflammations)
06/2023 - 01/2020
12
Amyloidosis
01/2022 - 01/2015
10
Amyloid Plaque
04/2024 - 12/2012
9
Tauopathies
11/2023 - 01/2017
8
Neuroinflammatory Diseases
06/2023 - 01/2015
7
Hypertension (High Blood Pressure)
08/2023 - 01/2015
7
Cerebral Cortical Thinning
01/2023 - 09/2015
6
Prodromal Symptoms
02/2020 - 07/2014
5
Genetic Predisposition to Disease (Genetic Predisposition)
05/2024 - 01/2017
5
Cerebrovascular Disorders (Cerebrovascular Occlusion)
01/2023 - 01/2017
5
Parkinson Disease (Parkinson's Disease)
05/2022 - 01/2013
4
Psychotic Disorders (Schizoaffective Disorder)
01/2024 - 06/2013
4
Obesity
01/2023 - 01/2013
3
Brain Diseases (Brain Disorder)
03/2024 - 12/2017
3
Pathologic Processes
01/2023 - 10/2019
3
Insulin Resistance
01/2023 - 01/2017
3
Traumatic Brain Injuries (Traumatic Brain Injury)
02/2022 - 08/2017
3
Proteostasis Deficiencies
01/2021 - 01/2017
3
Infarction (Infarctions)
01/2020 - 10/2011
2
Cerebral Small Vessel Diseases
02/2024 - 01/2022
2
Hallucinations (Hallucination)
01/2024 - 11/2023
2
Lewy Body Disease (Lewy Body Dementia)
10/2023 - 01/2017
2
Body Weight (Weight, Body)
01/2023 - 01/2018
2
Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2023 - 01/2023
2
Neurobehavioral Manifestations
11/2022 - 10/2014
2
Sleep Initiation and Maintenance Disorders (Insomnia)
01/2022 - 01/2021
2
Type 2 Diabetes Mellitus (MODY)
01/2022 - 01/2019
2
Frailty
01/2021 - 01/2020
2
Weight Loss (Weight Reduction)
01/2020 - 01/2018
2
Brain Injuries (Brain Injury)
02/2019 - 11/2015
Drug/Important Bio-Agent (IBA)
378
Biomarkers (Surrogate Marker)
IBA
05/2024 - 09/2010
308
Amyloid (Amyloid Fibrils)
IBA
05/2024 - 10/2011
109
Apolipoproteins E (ApoE)
IBA
04/2024 - 03/2012
52
Apolipoproteins
IBA
01/2024 - 06/2012
46
Glucose (Dextrose)
FDA Link
Generic
01/2024 - 12/2012
45
Amyloid beta-Peptides
IBA
04/2024 - 12/2012
40
Proteins (Proteins, Gene)
FDA Link
01/2024 - 10/2011
40
florbetapir
IBA
12/2023 - 01/2013
27
Apolipoprotein E4
IBA
05/2024 - 01/2015
20
7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indole
IBA
01/2024 - 01/2019
16
Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
FDA Link
01/2023 - 02/2013
13
tau Proteins (tau Protein)
IBA
12/2023 - 01/2018
10
Peptides (Polypeptides)
IBA
12/2023 - 01/2012
9
Indicators and Reagents (Reagents)
IBA
10/2023 - 10/2016
7
Cholinergic Agents (Cholinergics)
IBA
02/2024 - 12/2016
7
Complement System Proteins (Complement)
IBA
01/2024 - 01/2016
7
Lipids
IBA
06/2023 - 10/2013
6
Synucleins
IBA
01/2023 - 01/2013
6
4- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbene
IBA
01/2023 - 01/2020
6
Neurogranin
IBA
01/2022 - 11/2015
5
Brain-Derived Neurotrophic Factor (BDNF)
IBA
03/2024 - 09/2015
5
GAP-43 Protein (GAP 43 Protein)
IBA
01/2024 - 01/2022
5
Cholesterol
IBA
01/2023 - 05/2012
4
Genetic Markers (Genetic Marker)
IBA
03/2023 - 01/2015
4
Threonine (L-Threonine)
FDA Link
01/2023 - 01/2021
4
Homocysteine
IBA
01/2023 - 01/2015
4
Leptin
IBA
11/2022 - 01/2013
4
Insulin-Like Growth Factor Binding Protein 2
IBA
01/2022 - 01/2013
3
Insulin (Novolin)
FDA Link
05/2024 - 01/2013
3
Cerebrospinal Fluid Proteins
IBA
12/2023 - 09/2014
3
Hydrocortisone (Cortisol)
FDA Link
Generic
06/2023 - 01/2018
3
Insulin-Like Peptides
IBA
01/2023 - 12/2017
3
Adiponectin
IBA
11/2022 - 01/2020
3
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2022 - 11/2020
3
Ligands
IBA
01/2022 - 01/2020
3
Blood Proteins (Serum Proteins)
IBA
01/2022 - 10/2013
3
Cytokines
IBA
01/2022 - 01/2013
3
Enzymes
IBA
10/2019 - 01/2016
3
Blood Glucose (Blood Sugar)
IBA
01/2019 - 01/2017
3
2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)
IBA
10/2014 - 01/2012
2
Cell Adhesion Molecules
IBA
02/2024 - 01/2021
2
Fatty Acids (Saturated Fatty Acids)
IBA
11/2023 - 10/2013
2
DNA-Binding Proteins (DNA Binding Protein)
IBA
10/2023 - 01/2021
2
Elements
IBA
01/2023 - 09/2018
2
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
01/2023 - 01/2022
2
Hormones (Hormone)
IBA
01/2023 - 01/2017
2
Interleukin-3 (Interleukin 3)
IBA
12/2022 - 01/2022
2
C-Reactive Protein
IBA
12/2022 - 07/2021
2
Apolipoprotein E3
IBA
01/2022 - 01/2022
2
Iron
IBA
01/2022 - 01/2017
2
AZD4694
IBA
10/2021 - 01/2021
2
Radiopharmaceuticals
IBA
01/2021 - 03/2020
2
Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)
IBA
01/2021 - 11/2020
2
Messenger RNA (mRNA)
IBA
01/2021 - 01/2018
2
Prions
IBA
01/2021 - 10/2020
2
Antidepressive Agents (Antidepressants)
IBA
01/2021 - 01/2018
2
Fibrin
IBA
01/2020 - 01/2016
2
Sex Hormone-Binding Globulin
IBA
01/2020 - 01/2017
2
Pemetrexed (MTA)
FDA Link
09/2019 - 12/2017
Therapy/Procedure
16
Therapeutics
05/2024 - 01/2012
8
Activities of Daily Living (ADL)
01/2023 - 01/2017
3
Precision Medicine
04/2024 - 01/2022
3
Secondary Prevention
08/2022 - 01/2018